The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York RFK Jr. promotes peptides. Now the FDA weighs easing limits on the unproven chemicals Is BPC 157 Legal? Understanding Its Status and Implications BPC 157: Experimental Peptide Creates Risk for Athletes